Learning from the experience of collaborative research on ocular melanoma to improve the diagnosis and treatment level of uveal melanoma in China
10.3760/cma.j.cn511434-20230407-00155
- VernacularTitle:汲取眼部黑色素瘤协作研究经验，提高中国葡萄膜黑色素瘤诊疗水平
- Author:
Wenbin WEI
1
;
Nan ZHOU
Author Information
1. 首都医科大学附属北京同仁医院 北京同仁眼科中心 眼内肿瘤诊治研究北京市重点实验室 北京市眼科学与视觉科学重点实验室, 北京 100730
- Keywords:
Collaborative Ocular Melanoma Study;
Uveal melanoma;
Experience summary;
Diagnosis and treatment level;
Editorial
- From:
Chinese Journal of Ocular Fundus Diseases
2023;39(10):803-809
- CountryChina
- Language:Chinese
-
Abstract:
In the research process of uveal melanoma (UM), the Collaborative Ocular Melanoma Study (COMS) is a landmark and outstanding clinical study. Its research conclusions are the foundation for today's UM clinical work and guidelines. COMS is the first and largest randomized clinical trials conducted to date, comparing the survival outcomes of two or more treatment regimens for primary malignant intraocular tumors with high reliability. Its research design, methods, and conclusions are still widely cited in this day. Learning from the research experience of COMS, summarizing research data based on Asian populations, and studying treatment methods suitable for Asian UM patients is a powerful supplement to COMS data, but also an expansion of this global research, further improving the level of UM diagnosis and treatment in China.
